Medicare Enrolled

Dr. Mehdi Meratee, MD

Neurology · Valencia, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
28212 KELLY JOHNSON PKWY STE 235, Valencia, CA 91355
6612534900
In practice since 2007 (18 years)
NPI: 1164641510 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Meratee from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Meratee? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Meratee

Dr. Mehdi Meratee is a neurology specialist in Valencia, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Meratee performed 1,907 Medicare services across 1,189 unique beneficiaries.

Between the years covered by Open Payments, Dr. Meratee received a total of $13,418 from 58 pharmaceutical and/or device companies across 743 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Meratee is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 21% volume in CA $13,418 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,907
Medicare services
Top 21% in CA for neurology
1,189
Unique beneficiaries
$140
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~106 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
955 $109 $350
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
267 $153 $471
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
154 $90 $290
New patient office visit, complex (60-74 min) 139 $188 $675
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
85 $79 $234
EEG, extended monitoring
A test that records electrical activity in the brain while the patient is both awake and asleep.
77 $422 $1,500
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
60 $142 $540
Nerve conduction studies, 11-12
A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies.
50 $224 $858
Assessment of and care planning for patient with impaired thought processing, typically 60 minutes 38 $229 $700
Ultrasound of head and neck blood flow, bilateral
An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck.
25 $180 $595
Nerve conduction studies, 13 or more
A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed.
24 $259 $989
Nerve conduction studies, 5-6 tests
A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction.
17 $122 $462
Advance care planning consultation, first 30 min
A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion.
16 $72 $373
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$13,418
Total received (2018-2024)
Avg $1,917/year across 7 years
Top 20% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
58
Companies
743
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,932 (96.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$486 (3.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,973
2023
$2,021
2022
$3,010
2021
$2,623
2020
$874
2019
$1,257
2018
$1,659

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$719
Neurelis, Inc.
$201
PFIZER INC.
$180
Amgen Inc.
$168
Biogen, Inc.
$92
UCB, Inc.
$81
Eisai Inc.
$68
SK Life Science, Inc.
$61
Sumitomo Pharma America, Inc.
$61
Genentech USA, Inc.
$60
Celgene Corporation
$53
Kyowa Kirin, Inc.
$47
Novartis Pharmaceuticals Corporation
$45
TG Therapeutics, Inc.
$44
ARGENX US, INC.
$31
Teva Pharmaceuticals USA, Inc.
$30
Lilly USA, LLC
$18
Alexion Pharmaceuticals, Inc.
$15
Top 3 companies account for 55.8% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$1,888
Biogen, Inc.
$1,368
UCB, Inc.
$899
Amgen Inc.
$715
Supernus Pharmaceuticals, Inc.
$638
Novartis Pharmaceuticals Corporation
$509
SK Life Science, Inc.
$478
Genentech USA, Inc.
$404
Alexion Pharmaceuticals, Inc.
$369
Neurelis, Inc.
$367
Lilly USA, LLC
$349
Allergan, Inc.
$321
PFIZER INC.
$313
Biohaven Pharmaceuticals, Inc.
$311
AbbVie Inc.
$306
MDD US Operations, LLC
$285
Horizon Therapeutics plc
$282
LivaNova USA, Inc.
$275
Kyowa Kirin, Inc.
$243
Biohaven Pharmaceutical Holding Company Ltd.
$207
GENZYME CORPORATION
$206
ARGENX US, INC.
$196
Greenwich Biosciences, Inc.
$195
Eisai Inc.
$181
AstraZeneca Pharmaceuticals LP
$174
Neurocrine Biosciences, Inc.
$169
Teva Pharmaceuticals USA, Inc.
$166
ACADIA Pharmaceuticals Inc
$141
Mallinckrodt LLC
$133
Octapharma USA, Inc.
$114
GE Healthcare
$98
ARBOR PHARMACEUTICALS, INC.
$85
Avanir Pharmaceuticals, Inc.
$81
Janssen Pharmaceuticals, Inc
$80
Allergan Inc.
$72
EISAI INC.
$70
Sumitomo Pharma America, Inc.
$61
Boston Scientific Corporation
$56
Celgene Corporation
$53
US WorldMeds, LLC
$52
Sunovion Pharmaceuticals Inc.
$49
TG THERAPEUTICS, INC.
$44
TG Therapeutics, Inc.
$44
Acorda Therapeutics, Inc
$42
EMD Serono, Inc.
$42
Bayer HealthCare Pharmaceuticals Inc.
$39
Abbott Laboratories
$38
Lundbeck LLC
$32
MITSUBISHI TANABE PHARMA AMERICA, INC.
$25
IMPEL PHARMACEUTICALS INC.
$23
Merz North America, Inc.
$23
Adamas Pharmaceuticals, Inc.
$21
CSL Behring
$21
Jazz Pharmaceuticals Inc.
$19
Amneal Pharmaceuticals LLC
$18
Retrophin, Inc.
$15
Collegium Pharmaceutical, Inc.
$12
Travere Therapeutics, Inc.
$2
Top 3 companies account for 31.0% of all-time payments
Associated products mentioned in payments ›
(820) Cholbam · ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · ANDEXXA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Aduhelm · Aimovig · Austedo XR · BOTOX · BOTOX THERAPEUTIC · BRILINTA · BRIUMVI · Betaseron · Briviact · COMIRNATY · Cholbam · Cimzia · DAYBUE · Dayvigo · Deep Brain Stimulation · ELYXYB - celecoxib · EMGALITY · Epidiolex · Fycompa · GENERAL - DBS · GILENYA · GOCOVRI · General - EndoChoice · Hizentra · Horizant · INBRIJA · INGREZZA · KESIMPTA · Leqembi · MAYZENT · MS DISEASE STATE · MYOBLOC · Mavenclad · NAMZARIC · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OXTELLAR XR · Ocrevus · Ongentys · PANZYGA · Ponvory · QULIPTA · RADICAVA · RYTARY · SOLIRIS · Soliris · TECFIDERA · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS - Sentiva · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · XADAGO · XEOMIN · Xadago · Xyrem · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a neurology specialist in Valencia?
Compare neurologists in the Valencia area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
224
Per 100K population
2.3
County median income
$87,760
Nearest hospital
HENRY MAYO NEWHALL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Meratee is a clinical cardiology specialist, with above-average Medicare volume (top 21% in CA), with low-engagement industry engagement in the top 20% of CA peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Meratee experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Meratee performed 955 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Meratee receive payments from pharmaceutical companies?
Yes. Dr. Meratee received a total of $13,418 from 58 companies across 743 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Meratee's costs compare to other neurologists in Valencia?
Dr. Meratee's average Medicare payment per service is $140. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Meratee) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →